2014 has been described by many chronic lymphocytic leukemia (CLL) experts as a pivotal year for developing research and treatment. But are effective therapies in development to treat the full CLL spectrum? Dr. Javier Pinilla-Ibarz, a CLL expert from Moffitt Cancer Center, shares his views and explains the goal of researchers to treat patients with the right therapy at the right moment.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…